Clinical Trials Directory

Trials / Completed

CompletedNCT03799978

A Clinical Study to Investigate the Food Effect on the Pharmacokinetics of ACT-541468 in Healthy Male Subjects

A Single-center, Open-label, Randomized, Two Way Crossover Study to Investigate the Food Effect on the Pharmacokinetics of ACT-541468 in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Idorsia Pharmaceuticals Ltd. · Industry
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This is a single-center, open-label, randomized, two way crossover study to investigate the food effect on the pharmacokinetics of ACT-541468 in healthy male subjects.

Conditions

Interventions

TypeNameDescription
DRUGACT-541468ACT-541468 50 mg film-coated tablets

Timeline

Start date
2019-03-09
Primary completion
2019-03-18
Completion
2019-03-18
First posted
2019-01-10
Last updated
2019-04-12

Locations

1 site across 1 country: Czechia

Regulatory

Source: ClinicalTrials.gov record NCT03799978. Inclusion in this directory is not an endorsement.